F.L. Putnam Investment Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $260K | Buy |
6,780
+768
| +13% | +$29.5K | ﹤0.01% | 516 |
|
|
2025
Q1 | $233K | Buy |
6,012
+98
| +2% | +$3.8K | ﹤0.01% | 527 |
|
|
2024
Q4 | $200K | Sell |
5,914
-6,524
| -52% | -$221K | ﹤0.01% | 550 |
|
|
2024
Q3 | $482K | Buy |
12,438
+401
| +3% | +$15.6K | 0.01% | 435 |
|
|
2024
Q2 | $463K | Buy |
12,037
+3,401
| +39% | +$131K | 0.01% | 428 |
|
|
2024
Q1 | $370K | Buy |
8,636
+3,234
| +60% | +$139K | 0.01% | 381 |
|
|
2023
Q4 | $200K | Buy |
+5,402
| New | +$200K | ﹤0.01% | 464 |
|
|
2020
Q3 | – | Sell |
-5,516
| Closed | -$281K | – | 305 |
|
|
2020
Q2 | $281K | Sell |
5,516
-21
| -0.4% | -$1.07K | 0.02% | 260 |
|
|
2020
Q1 | $262K | Buy |
5,537
+1,290
| +30% | +$61K | 0.02% | 248 |
|
|
2019
Q4 | $249K | Buy |
4,247
+2
| +0% | +$117 | 0.02% | 281 |
|
|
2019
Q3 | $226K | Buy |
4,245
+524
| +14% | +$27.9K | 0.02% | 268 |
|
|
2019
Q2 | $186K | Buy |
+3,721
| New | +$186K | 0.02% | 223 |
|